StockData
Inspire Medical Systems, Inc. logo

Inspire Medical Systems, Inc. (INSP) company profile

INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3057% below fair value
$59.41+0.29 (+0.49%)

Close on Nov 17, 2026Market cap $1.72BP/E 12.9Yield –

About Inspire Medical Systems

Surgical & Medical Instruments & Apparatus, SIC 3841

The company develops and commercializes minimally invasive neurostimulation technologies for patients with obstructive sleep apnea. Its main product is the Inspire system, including the Inspire IV and Inspire V models, which monitors breathing and delivers mild hypoglossal nerve stimulation to keep airways open during sleep. The system includes an implantable neurostimulator, leads, a remote control, and the digital SleepSync management platform. The company sells its medical devices to hospitals and ambulatory surgery centers, while collaborating with ear, nose, and throat doctors, sleep centers, and patients.

As of December 31, 2025, the firm maintains 295 sales territories across the United States and 21 international territories. It markets directly to healthcare providers in the United States and select European countries, and uses distributors in Asian markets including Japan, Singapore, Hong Kong, and Thailand. More than 125,000 patients have received the therapy across the United States, Europe, and Asia. The provided text does not state the company's headquarters.

Summary of the business section of Inspire Medical Systems's latest annual report, written by StockData.

Company profile

Company

Legal name
Inspire Medical Systems, Inc.
Founded
2007
Headquarters
Golden Valley, MN
Address
5500 Wayzata Blvd, Suite 1600 55416
Phone
(763) 957-5037
Employees
1,333, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, Minneapolis, MN

Stock & identifiers

Ticker
INSP
Exchange
NYSE
IPO date
May 4, 2018
Shares outstanding
29M, Jul 30, 2026
Public float
$3.80B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1609550
CUSIP
457730109
ISIN
US4577301090
FIGI
BBG00209SZJ7
Share class FIGI
BBG00209SZK5
LEI
549300XQQCQ7HCJKTW25
EIN
26-1377674

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Timothy P. HerbertCEO and President, Director105,349
Jason P. KellySee Remarks25,335
Melissa MannChief People Officer22,957
John RondoniSee Remarks27,165
Bryan K. PhillipsSee Remarks38,513
Carlton WeatherbySee Remarks41,679
Matthew J. OsbergChief Financial Officer19,794
Richard BuchholzInterim CFO45,463
Randy BanSee Remarks9,303
Michael H. CarrelDirector5,834
Shelley G. BroaderDirector9,138
Georgia MelenikiotouDirector8,584
Gary Lee EllisDirector11,850
Casey M. TanseyDirector27,132
Shawn mcCormickDirector30,712
Cynthia BurksDirector6,213
Dana G. Mead Jr.Director26,213
Myriam CuretDirector6,927

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$7.71M-$869.71K$2.74M$49$78
FY2024$8.11M$2.50M$2.85M$99$78
FY2023$7.49M$876.35K$2.18M$108$74
FY2022$5.68M$8.35M$2.14M$134$79
FY2021$1.27M$10.64M$1.13M$122$103
FY2020$4.87M$21.66M$2.46M$253$133

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Timothy P. Herbert
President and Chief Executive Officer
$750.57K$6.00M$961.56K–$7.71M-5%
Randall A. Ban
Chief Commercial Officer (6)
$490.79K$1.90M$328.05K$10.50K$2.73M-4%
Richard J. Buchholz
Chief Financial Officer (6)
$477.99K$1.90M$319.49K$10.26K$2.71M-4%
Bryan K. Phillips
SVP, General Counsel, CCO and Corporate Secretary
$475.18K$1.90M$317.61K$9.74K$2.70M-5%
Carlton W. Weatherby
Chief Strategy Officer (6)
$506.25K$1.90M$428.89K–$2.84M-2%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
May 4, 2018
Offer price
$16.00
Securities offered
6,750,000
Gross proceeds
$108.00M
Exchange
NYSE
First trading day
May 3, 2018
First-day close
$24.98+56.1%
Lock-up ends (est.)
Oct 30, 2018

“Per Share Total Public offering price $16.00 $108,000,000 Underwriting discount(1) $1.12 $7,560,000 Proceeds, before expenses, to us $14.88 $100,440,000 (1) We refer you to "Underwriting" beginning on page 166 for additional information regarding underwriting compensation.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 1,333 employees, of which 1,243 are in the U.S., 83 are in Europe and 7 are in Japan.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?